Michaela Neprašová

568 total citations
16 papers, 309 citations indexed

About

Michaela Neprašová is a scholar working on Nephrology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Michaela Neprašová has authored 16 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 9 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Michaela Neprašová's work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Michaela Neprašová is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Michaela Neprašová collaborates with scholars based in Czechia, Denmark and United States. Michaela Neprašová's co-authors include Vladimı́r Tesař, Dita Maixnerová, Jan Novák, Colin Reily, Eva Honsová, Qi Bian, Miloslav Suchánek, Tomáš Zima, Romana Ryšavá and Jana Reiterová and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Michaela Neprašová

16 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Neprašová Czechia 9 247 59 59 56 54 16 309
Shane A. Bobart United States 9 236 1.0× 79 1.3× 33 0.6× 26 0.5× 118 2.2× 28 296
Peiran Yin China 8 169 0.7× 40 0.7× 62 1.1× 48 0.9× 27 0.5× 13 223
Masami Fujisaki Japan 7 180 0.7× 70 1.2× 56 0.9× 31 0.6× 33 0.6× 8 291
Yuya Hashimura Japan 9 211 0.9× 55 0.9× 52 0.9× 99 1.8× 88 1.6× 18 429
Yaling Zhai China 9 290 1.2× 58 1.0× 215 3.6× 97 1.7× 49 0.9× 22 386
Kiyonobu Ishizuka Japan 8 158 0.6× 51 0.9× 32 0.5× 14 0.3× 40 0.7× 35 253
Durga Kanigicherla United Kingdom 9 371 1.5× 162 2.7× 51 0.9× 42 0.8× 191 3.5× 27 407
Nadia Dallera Italy 7 315 1.3× 135 2.3× 36 0.6× 53 0.9× 113 2.1× 16 370
Qianxu Guo United States 7 105 0.4× 40 0.7× 22 0.4× 117 2.1× 45 0.8× 9 323
Makiko Nakayama Japan 9 340 1.4× 135 2.3× 58 1.0× 75 1.3× 54 1.0× 17 515

Countries citing papers authored by Michaela Neprašová

Since Specialization
Citations

This map shows the geographic impact of Michaela Neprašová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Neprašová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Neprašová more than expected).

Fields of papers citing papers by Michaela Neprašová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Neprašová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Neprašová. The network helps show where Michaela Neprašová may publish in the future.

Co-authorship network of co-authors of Michaela Neprašová

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Neprašová. A scholar is included among the top collaborators of Michaela Neprašová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Neprašová. Michaela Neprašová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Neprašová, Michaela, Dita Maixnerová, Federica Genovese, et al.. (2023). Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy. Biomolecules. 13(7). 1093–1093. 8 indexed citations
2.
Neprašová, Michaela, Dita Maixnerová, Federica Genovese, et al.. (2023). Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy. International Journal of Molecular Sciences. 24(3). 2064–2064. 8 indexed citations
3.
Honsová, Eva, Romana Ryšavá, Michaela Neprašová, et al.. (2021). Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma. Journal of Nephrology. 35(2). 675–678. 1 indexed citations
4.
Maixnerová, Dita, Petra Hrubá, Michaela Neprašová, et al.. (2021). Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation. Frontiers in Immunology. 12. 726215–726215. 9 indexed citations
5.
Genovese, Federica, Daniel Guldager Kring Rasmussen, M.A. Karsdal, et al.. (2021). Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 37(6). 1099–1108. 32 indexed citations
6.
Maixnerová, Dita, Stacy Hall, Colin Reily, et al.. (2019). Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression. PLoS ONE. 14(2). e0212254–e0212254. 45 indexed citations
7.
Ciferská, Hana, Eva Honsová, Alena Lodererová, et al.. (2019). Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?. Journal of Nephrology. 33(2). 307–316. 17 indexed citations
8.
Genovese, Federica, M.A. Karsdal, Dita Maixnerová, et al.. (2018). FP275A BIOMARKER OF COLLAGEN TYPE III DEGRADATION DECREASES WITH INCREASING FIBROSIS IN THE KIDNEY OF PATIENTS WITH IgA NEPHROPATHY. Nephrology Dialysis Transplantation. 33(suppl_1). i124–i124. 1 indexed citations
9.
Genovese, Federica, M.A. Karsdal, Michaela Neprašová, et al.. (2018). FP274A NOVEL BIOMARKER OF TYPE VI COLLAGEN FORMATION MEASURED IN SERUM AND URINE OF PATIENTS WITH IgA NEPHROPATHY REFLECTS THE LEVEL OF FIBROSIS IN THE KIDNEYS. Nephrology Dialysis Transplantation. 33(suppl_1). i123–i124. 1 indexed citations
10.
Přikryl, P., Lucy Vojtová, Dita Maixnerová, et al.. (2017). Proteomic Approach for Identification of IgA Nephropathy-Related Biomarkers in Urine. Physiological Research. 66(4). 621–632. 17 indexed citations
11.
Neprašová, Michaela, Dita Maixnerová, Jan Novák, et al.. (2016). Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study. Disease Markers. 2016. 1–9. 21 indexed citations
12.
Maixnerová, Dita, Colin Reily, Qi Bian, et al.. (2016). Markers for the progression of IgA nephropathy. Journal of Nephrology. 29(4). 535–541. 61 indexed citations
13.
Maixnerová, Dita, Eva Jančová, J Skibová, et al.. (2014). Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011. Journal of Nephrology. 28(1). 39–49. 63 indexed citations
14.
Maixnerová, Dita, Michaela Neprašová, J Skibová, et al.. (2014). IgA Nephropathy in Czech Patients - Are We Able Reliably Predict the Outcome?. Kidney & Blood Pressure Research. 39(6). 555–562. 7 indexed citations
15.
Maixnerová, Dita, Vladimı́r Tesař, Romana Ryšavá, et al.. (2013). The coincidence of IgA nephropathy and Fabry disease. BMC Nephrology. 14(1). 6–6. 16 indexed citations
16.
Hrušková, Zdenka, et al.. (2011). [Peritoneal dialysis and its modification in the treatment of chronic renal failure].. PubMed. 57(7-8). 635–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026